Dr. Max Lenz | Health Professions | Young Scientist Award
Resident Phycisian | Medical university of vienna, Austria
Priv. Doz. Dr. med. univ. Max Lenz, PhD, is an Austrian specialist in Internal Medicine and Cardiology at the Medical University of Vienna. He pursued medical studies at the Medical University of Vienna. He completed his PhD in Vascular Biology in 2023 and obtained Venia Docendi in 2024. His clinical and research expertise lies in ischemia-reperfusion injury, inflammatory responses, and cardiac biomarkers. Dr. Lenz has authored numerous publications and received prestigious awards for his contributions to cardiovascular medicine.
Publication Profile
🎓Education
Dr. Lenz attended Ätsch Schule for primary education and Neulandschule Laaerberg for secondary school. He pursued medical studies at the Medical University of Vienna, where he later enrolled in a PhD program (n094) focusing on Vascular Biology from 2016 to 2023. In 2024, he was awarded Venia Docendi, recognizing his academic expertise and teaching qualification in medicine.
💼Experience
Dr. Lenz began his professional career as a Study Coordinator at the Division of Cardiology, Medical University of Vienna (2017–2018). He pursued a PhD in Vascular Biology (2016–2023) while completing his residency at the Medical University of Vienna (2018–2024). In 2024, he was appointed Specialist for Internal Medicine and Cardiology at the Division of Cardiology, where he continues his clinical and academic endeavors.
🏆Awards and Honors
Dr. Lenz has received multiple prestigious awards, including the ÖKG Grant (2017) for his research on mitochondrial DNA in ischemia-reperfusion injury. He won the CVC Publication Prize (2022) for his work on intracellular Na+ modulation in inflammatory response. In 2023, he received the Best Abstract Prize at ÖSKIM for his study on NSE measurements in ICU patients. In 2024, he was awarded the Medizinisch-Wissenschaftlichen Fonds des Bürgermeisters der Bundeshauptstadt Wien for research on inflammatory markers in fulminant myocarditis.
🔬Research Focus
Dr. Lenz’s research focuses on vascular biology, ischemia-reperfusion injury, mitochondrial function, and inflammatory processes in cardiology. His work explores pharmacologic modulation of intracellular Na+ levels, biomarkers for cardiac risk stratification, and immune responses in myocardial infarction and myocarditis. His studies have significantly contributed to understanding cardiovascular pathophysiology, with 13 first/last-author publications and 22 co-authored papers.
Conclusion
Dr. Max Lenz is a highly competitive candidate for the Young Scientist Award, given his outstanding research achievements, academic excellence, and contributions to cardiology. Expanding international collaborations and leadership roles could further solidify his profile as a top contender.
Publications
-
Title: Routinely Available Inflammatory Biomarkers Are Not Associated With Target Lesion Revascularization After Coronary Intervention
Year: 2025
Authors: Eva Steinacher, Andreas Hammer, Ulrike Baumer, Lorenz Koller, Alexander Niessner
-
Title: Urinary Output as a Predictor of Mortality in Cardiogenic Shock: An Explorative Retrospective Analysis
Year: 2024
Authors: Sebastian Markart, Alexander Hermann, Florian Chiari, Thomas Staudinger, Robert Zilberszac
-
Title: NT-proBNP Reflects Left Ventricular Hypertrophy Rather than Left Ventricular Dilatation or Systolic Dysfunction in Patients with Fabry Disease
Year: 2024
Authors: Constantin Gatterer, Dietrich Beitzke, Gère Sunder-Plaßmann, Senta Graf, Max Lenz